New CDC population data from 2023 show that in 23 states more than one in three adults (35%) has obesity. Before 2013, no state had an adult obesity prevalence at or above 35%. Currently, at least one ...

A weight loss drug prescribed to adults to treat obesity is safe and effective in children as young as six, new research has revealed. Liraglutide – sold under the brand names Saxenda and Victoza – is ...

As of 2020, the United States’ obesity epidemic impacts over 40% of the adult population. Although the CDC recognized this highly prevalent and serious ...

This summary covers several health-related news, including Germany's bird flu outbreak, Bristol Myers' lawsuit victory, ...

The injectable tracer, Flyrcado, could help doctors flag deadly coronary artery disease in patients during imaging tests.

The disparity in life expectancy and health quality between urban and rural men approaching retirement has grown over the ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

The Swiss pharma is paying Regor Therapeutics $850 million to buy a pair of prospects it sees as potential successors to blockbuster medicines from Pfizer and Eli Lilly.

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.